Nymox Pharmaceutical
NYMX
#10365
Rank
ยฃ13.6 M
Marketcap
Country
ยฃ0.15
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -ยฃ1.83 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -ยฃ4.87 Million, an increase over its 2021 earnings that were of -ยฃ9.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -ยฃ1.83 Million-62.47%
2022 -ยฃ4.87 Million-47.71%
2021 -ยฃ9.31 Million6.61%
2020 -ยฃ8.73 Million-10.91%
2019 -ยฃ9.8 Million24.24%
2018 -ยฃ7.89 Million-20.03%
2017 -ยฃ9.87 Million2.71%
2016 -ยฃ9.61 Million-63.86%
2015 -ยฃ26.57 Million674.44%
2014 -ยฃ3.44 Million-6.11%
2013 -ยฃ3.66 Million-35.66%
2012 -ยฃ5.68 Million-20.76%
2011 -ยฃ7.17 Million38.33%
2010 -ยฃ5.19 Million35.59%
2009 -ยฃ3.83 Million11.8%
2008 -ยฃ3.42 Million-12.94%
2007 -ยฃ3.93 Million8.85%
2006 -ยฃ3.61 Million36.5%
2005 -ยฃ2.65 Million-4.4%
2004 -ยฃ2.77 Million-14.58%
2003 -ยฃ3.24 Million
2001 -ยฃ2.38 Million-20.54%
2000 -ยฃ2.99 Million21.72%
1999 -ยฃ2.46 Million-25.56%
1998 -ยฃ3.3 Million101.3%
1997 -ยฃ1.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.37 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ7.89 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.06 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.20 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ1.02 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA